In Elon's Silicon Valley, Drug Use Was Par for the Course | Elon, Inc.

In this week’s episode of Elon, Inc., we conclude a series of “jealousy interviews” where we talk to authors of Elon Musk stories we wish we had written. This time, Bloomberg News Musk reporter Dana Hull chats with Kirsten Grind of the New York Times about her May exposé ()on the alleged campaign trail drug habits of a certain entrepreneurturnedaspiring political kingmaker.

The conversation covers not only Musk’s reported drug use (which he has denied ()) but the prevalence of drugs in Silicon Valley and across the tech industry as well. “All these tech guys think they can disrupt everything and they want to also disrupt their health,” Grind says. “So they kind of think they can medicate themselves a lot of the times.” Hull and Grind also talk about the broader themes of Musk’s salad days, back when he juggled not only a grueling schedule but private legal battles involving his many children.

See omnystudio.com/listener () for privacy information.

Elon Musk’s sprawling business empire has granted the billionaire a degree of power and global influence that transcends the industries he’s reshaped. He is the leader of no fewer than six hugely influential companies, spanning electric vehicles to wartime communications, and their innovations could shape the fates of nations.

Musk is polarizing, confounding and inescapable. And he is the biggest business story of our time.

Each week, listen in as host David Papadopoulos convenes a panel of Bloomberg Businessweek journalists who are tracking Musk’s companies and the surprising ways they intersect. They break down the business mogul's latest moves and analyze what they could mean for us all.

Subscribe to Bloomberg Podcasts

Listen to more Elon, Inc.

#ElonMusk #Bloomberg #Podcast #Elon

Follow Bloomberg Podcasts on Twitter

Visit our other YouTube channels:

Bloomberg Television

Bloomberg Originals

For coverage on news, markets and more